Evidence that lipoproteins are carriers of bioactive factors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2412-2421

  Sachinidis, Agapios ^a   Kettenhofen, Ralf ^a   Seewald, Stefan ^a   Gouni Berthold, Ioanna ^a   Schmitz, Udo ^a   Seul, Claudia ^a   Ko, Yon ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Lipoproteins; MAP kinases; Pertussis toxin; Vascular smooth muscle cells

Indexed keywords

CALCIUM ION; CELL DNA; CHLOROFORM; HIGH DENSITY LIPOPROTEIN; ISOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; METHANOL; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE FRAGMENT; PERTUSSIS TOXIN; PROTEIN C FOS; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; VERY LOW DENSITY LIPOPROTEIN; WATER;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA DETERMINATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0032856201     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2412     Document Type: Article

References (41)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 1993;362:801-809.
2. Brown SM, Goldstein LJ. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-37.
3. Scott-Burden T, Resink TJ, Hahn AW, Baur U, Box RJ, Buehler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem. 1989;264: 12582-12589.
4. Sachinidis A, Mengden T, Locher R, Brunner C, Vetter W. Novel cellular activities for low-density lipoprotein in vascular smooth muscle cells. Hypertension. 1990;15:704-711.
5. Sachinidis A, Ko Y, Wieczorek A, Weisser B, Locher R, Vetter W, Vetter H. Lipoprotein induces expression of the early growth response gene-1 in vascular smooth muscle cells from rat. Biochem Biophys Res Commun. 1993;192:794-799.
6. Libby P, Miao P, Ordovas JM, Schäfer EJ. Lipoproteins increase growth of mitogen stimulated arterial smooth muscle cells. J Cell Physiol. 1985; 124:1-8.
7. Chen JK, Hoshi H, McClure DB, McKeehan W. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J Cell Physiol. 1986;129:207-214.
8. Sachinidis A, Seewald S, Epping P, Seul C, Ko Y, Vetter H. The growth promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol Pharmacol. 1997;52:389-397.
9. i and DNA synthesis in rat aortic smooth muscle cells. Hypertension. 1997;29: 326-333.
10. Nickenig G, Sachinidis A, Michaelson F, Böhm M, Seewald S, Vetter H. Up-regulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells. Circulation. 1997; 95:473-478.
11. Seewald S, Nickenig G, Ko Y, Vetter H, Sachinidis A. Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells. Cardiovasc Res. 1997;36:92-100.
12. Ko Y, Totzke G, Seewald S, Schmitz U, Schiermeyer B, Meyer zu Brickwedde M, Vetter H, Sachinidis A. Native low-density lipoprotein (LDL) induces the expression of the early-growth response gene-1 in human umbilical arterial endothelial cells. Eur J Cell Biol. 1995;68: 306-312.
13. Durieux ME, Lynch KR. Signalling properties of lysophosphatidic acid. Trends Pharmacol Sci. 1993;14:249-255.
14. Spiegel S, Merrill AHJ. Sphingolipids metabolism and cell growth regulation. FASEB J. 1996;10:1388-1397.
15. Bitar KN, Yamada H. Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol. 1995;269:G370-G377.
16. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
17. Chamley JH, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;39:1-61.
18. 2 and vascular smooth muscle cell proliferation. Hypertension. 1995;26:771-780.
19. Redgrave TG, Robert DCK, West CE. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975;65:42-49.
20. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
21. Wessel D, Flügge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984;138:141-143.
22. Breton L, Sorklz B. A rapid method for phospholipid separation by HPLC with light scattering detection. J Chromatogr. 1989;497:243-249.
23. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260:3440-3450.
24. Marshall CJ. Specifity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995;80:179-185.
25. Deeg MA, Bowen RF, Oram JF, Bierman EL. High density lipoproteins stimulate mitogen-activated protein kinases in human skin fibroblasts. Arterioscler Thromb Vasc Biol. 1997;17:1667-1674.
26. Himber J, Bühler E, Moll D, Moser UK. Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop. Int J Vitam Nutr Res. 1995;65:137-142.
27. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jürgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 1990;3:77-92.
28. Sachinidis A, Locher R, Mengden T, Vetter W. Low-density lipoprotein elevates intracellular calcium and pH in vascular smooth muscle cells and fibroblasts without mediation of LDL receptor. Biochem Biophys Res Commun. 1990;167:353-359.
29. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 1997;17:141-148.
30. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: Upstream regulators of the c-Jun amino-terminal kinases. Curr Opin Gen Dev. 1997;7:67-74.
31. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
32. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361662 men. Lancet. 1986;2:933-936.
33. Smith EB, Slater RS. Relationship between low-density lipoprotein in aortic intima and serum-lipid levels. Lancet. 1972;1:463:463-469.
34. Vasile E, Simionescu M, Simionescu N. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in arterial endothelium in situ. J Cell Biol. 1983;96:1677-1689.
35. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein (a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis. 1988;8:851-857.
36. Daly MM. Effect of hypertension on the lipid composition of rat aortic intima-media. Circ Res. 1972;31:410-416.
37. Robertson AL, Khairallah PA. Arterial endothelial permeability and vascular diseases, the "trap door" effect. Exp Mol Pathol. 1973;18:241-260.
38. Bjorkerud S, Bjorkerud B. Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts. Arterioscler Thromb. 1994;14:288-298.
39. Resink TJ, Bochkov VN, Hahn AW, Philipova MP, Buhler FR, Tkachuk VA. Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells. J Vasc Res. 1995;32:328-338.
40. Hahn A, Ferracin F, Buhler F, Pletcher A. Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;178:1465-1471.
41. Saxena U, Klein MG, Vanni TM, Goldberg IJ. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J Clin Invest. 1992;89:373-380.